Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues

Authors :: Cornelius Donat
Markus Laube
Klaus Kopka
Hans-Jurgen Pietzsch
Jens Pietzsch
Reik Loeser
Robert Wodtke
Source :: Nuclear Medicine and Biology. :S220
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Cancer Research
Molecular Medicine
Radiology, Nuclear Medicine and imaging

Tools